Lenalidomide and Dexamethasone for Rosai-Dorfman Disease
Condition(s):Rosai-Dorfman DiseaseLast Updated:June 16, 2021Recruiting
Hide Studies Not Open or Pending
Condition(s):Rosai-Dorfman DiseaseLast Updated:June 16, 2021Recruiting
Condition(s):Rosai-Dorfman Disease; Langerhans Cell HistiocytosisLast Updated:March 17, 2022Unknown status
Condition(s):Langerhans Cell Histiocytosis (LCH); Juvenile Xanthogranuloma (JXG); Rosai-Dorfman Disease (RDD); Histiocytic DisordersLast Updated:February 7, 2024Recruiting
Condition(s):Non-Hodgkin Lymphoma; Multiple Myeloma; Histiocytic Neoplasms; Erdheim-Chester Disease; Rosai-Dorfman DiseaseLast Updated:September 1, 2023Recruiting
Condition(s):HistiocytosisLast Updated:February 8, 2024Active, not recruiting
Condition(s):Histiocytosis; Langerhans Cell Histiocytosis; Erdheim-Chester Disease; Rosai Dorfman Disease; Xanthogranuloma; Malignant HistiocytosesLast Updated:June 22, 2023Recruiting
Condition(s):Langerhan’s Cell Histiocytosis; Juvenile Xanthogranuloma; Erdheim-Chester Disease; Rosai Dorfman Disease; Neuro-Degenerative Disease; Histiocytic Sarcoma; Histiocytic Disorders, MalignantLast Updated:March 15, 2023Recruiting
Condition(s):Rare Histiocytic Disorders (RHDs); Juvenile Xanthogranuloma (JXG); Reticulohistiocytoma (Epithelioid Histiocytoma); Xanthoma Disseminatum (XD); Multicentric Reticulohistiocytosis (MRH); Systemic Juvenile Xanthogranuloma; Erdheim-Chester Disease (ECD); Multi-system Rosai-Dorfman Disease (RDD)Last Updated:December 15, 2022Active, not recruiting
Condition(s):Erdheim-Chester DiseaseLast Updated:December 11, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.